Global Biopharma Continues Work with Thought Leader Select for KOL Initiatives in COPD
October 3, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, recently earned new work in developing key opinion leader (KOL) strategies in support of new treatments for chronic obstructive pulmonary disorder (COPD) for a top global biopharmaceutical concern. The client company, one of the world’s top ten industry leaders …
Global Biopharma Continues Work with Thought Leader Select for KOL Initiatives in COPD Read More »
